PTL 78968

Drug Profile

PTL 78968

Alternative Names: PTL 419; PTL 7819-B; PTL 78419; PTL 78419-B

Latest Information Update: 17 Jul 2001

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Peptech
  • Class Antibacterials; Peptide antibiotics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections; Mycoses; Tuberculosis

Most Recent Events

  • 17 Jul 2001 Discontinued-Preclinical for Bacterial infections in Australia (Injection)
  • 17 Jul 2001 Discontinued-Preclinical for Mycoses in Australia (Injection)
  • 17 Jul 2001 Discontinued-Preclinical for Tuberculosis in Australia (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top